Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (Q3)Jan 31, 2026 | (Q2)Oct 31, 2025 | (Q1)Jul 31, 2025 | (FY)Apr 30, 2025 | (Q4)Apr 30, 2025 | (Q3)Jan 31, 2025 | (Q2)Oct 31, 2024 | (Q1)Jul 31, 2024 | (FY)Apr 30, 2024 | (Q4)Apr 30, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 70.91%-65.13K | -79.41%-131.55K | 66.66%-176.72K | -21.02%-926.7K | -128.58%-99.43K | 19.07%-223.89K | 74.40%-73.33K | -12.21%-530.05K | -5.52%-765.73K | -118.97%-43.5K |
| Net income from continuing operations | 84.24%-285.41K | 49.40%-382.99K | 26.22%-705.02K | -551.14%-4.53M | -703.95%-1.01M | -1,168.39%-1.81M | -2,750.77%-756.85K | -525.04%-955.62K | 10.37%-696.25K | 80.03%-125.66K |
| Operating gains losses | ---- | ---- | ---- | 3,241.96%1.41M | 99.92%-110 | ---- | ---- | ---- | 129.62%42.32K | -211.64%-138.5K |
| Depreciation and amortization | -90.79%22.23K | -87.72%42.04K | -86.83%45.2K | 960.08%980.02K | 50.17%53.06K | 186,877.74%241.35K | 257,250.46%342.4K | 231,798.65%343.21K | 12,920.70%92.45K | 21,458.65%35.33K |
| Asset impairment expenditure | ---- | ---- | ---- | 766.94%560.04K | ---- | ---- | ---- | ---- | --64.6K | ---- |
| Unrealized gains and losses of investment securities | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---9.66K | ---- |
| Remuneration paid in stock | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --55.08K | ---- |
| Deferred tax | ---- | ---- | ---- | --67K | ---- | ---- | ---- | ---- | --0 | ---- |
| Other non cashItems | -98.73%19.46K | -120.68%-19.33K | -32.49%81.42K | 312.09%342.98K | -2,310.30%-1.4M | 1,744.62%1.53M | 154.00%93.49K | --120.6K | -256.73%-161.71K | -84.02%63.22K |
| Change In working capital | 198.87%178.58K | -7.60%228.73K | 1,153.04%401.68K | 259.09%242.69K | 1,668.84%213.92K | -77.91%-180.63K | 306.12%247.54K | 85.98%-38.15K | -269.22%-152.55K | -96.43%12.09K |
| -Change in receivables | -124.48%-51.97K | 226.23%145.94K | -10.20%64.85K | 1,063.59%497.54K | 725.21%328.64K | 11,215.18%212.31K | -2,541.17%-115.62K | 876.38%72.21K | -5,410.57%-51.63K | -4,369.55%-52.57K |
| -Change in inventory | -22.25%75.28K | -82.99%147.18K | 187.89%284.45K | --584.01K | ---54.67K | --96.82K | --865.49K | ---323.64K | --0 | --0 |
| -Change in prepaid assets | -146.80%-23.32K | 131.48%27.2K | -112.97%-3.63K | 113.16%42.53K | 176.55%51.11K | --49.82K | -6,928.37%-86.41K | 153.49%28K | -437.23%-323.09K | 8.26%-66.78K |
| -Change in payables and accrued expense | 133.10%178.59K | 77.98%-91.59K | -69.77%56.02K | -496.71%-881.4K | -184.58%-111.17K | -5,957.20%-539.58K | -3,263.26%-415.93K | 181.60%185.28K | 46.92%222.18K | 78.50%131.43K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 70.91%-65.13K | -79.17%-131.55K | 66.65%-176.72K | -21.02%-926.7K | -128.58%-99.43K | 19.07%-223.89K | 74.36%-73.43K | -12.19%-529.95K | -5.52%-765.73K | -118.97%-43.5K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 88.71%-20.3K | -34.37K | -15.08%-440.87K | 41.99%-108K | -152.98K | -179.88K | 0 | -1.69%-383.1K | -186.17K |
| Net PPE purchase and sale | --0 | 86.11%-20.3K | ---34.37K | -134.57%-404.89K | -18.22%-105.3K | ---153.4K | ---146.19K | --0 | ---172.61K | ---89.08K |
| Net business purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --49.3K | ---- |
| Net investment purchase and sale | --0 | ---- | ---- | ---35.97K | ---2.7K | --415 | ---- | ---- | --0 | --0 |
| Interest received (cash flow from investment activities) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --49.3K | ---- |
| Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 31.04%-259.79K | ---146.39K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | 88.71%-20.3K | ---34.37K | -15.08%-440.87K | 41.99%-108K | ---152.98K | ---179.88K | --0 | -1.69%-383.1K | ---186.17K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 86.10%-22.5K | 75.19%-38.01K | 71.82%-52.89K | -499.43%-560.51K | 18.89%-57.79K | -622.99%-161.83K | -153.22K | -187.67K | -93.51K | -71.25K |
| Net issuance payments of debt | 86.10%-22.5K | 75.19%-38.01K | 71.82%-52.89K | -499.43%-560.51K | 18.89%-57.79K | -622.99%-161.83K | ---153.22K | ---187.67K | ---93.51K | ---71.25K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 86.10%-22.5K | 75.19%-38.01K | 71.82%-52.89K | -499.43%-560.51K | 18.89%-57.79K | -622.99%-161.83K | ---153.22K | ---187.67K | ---93.51K | ---71.25K |
| Net cash flow | ||||||||||
| Beginning cash position | -90.61%131.33K | -84.17%317.16K | -76.58%598.22K | -33.09%2.55M | -71.22%847.22K | -56.62%1.4M | -40.73%2M | -33.11%2.55M | -26.19%3.82M | -27.50%2.94M |
| Current changes in cash | 83.73%-87.64K | 53.29%-189.87K | 63.22%-263.97K | -55.20%-1.93M | 11.86%-265.22K | -80.15%-538.7K | -41.93%-406.52K | -73.60%-717.62K | -12.70%-1.24M | -104.18%-300.91K |
| Effect of exchange rate changes | 9.28%-10.91K | 102.03%4.04K | -110.26%-17.08K | -33.53%-28.29K | 118.56%16.22K | -162.89%-12.03K | -774.65%-199.01K | 51.54%166.53K | 91.62%-21.19K | 71.29%-87.4K |
| End cash Position | -96.13%32.78K | -90.61%131.33K | -84.17%317.16K | -76.58%598.22K | -76.58%598.22K | -71.21%847.22K | -55.24%1.4M | -43.01%2M | -33.09%2.55M | -33.09%2.55M |
| Free cash from | 82.74%-65.13K | 30.85%-151.86K | 60.17%-211.08K | -41.91%-1.33M | -54.43%-204.73K | -36.38%-377.29K | 23.32%-219.62K | -12.19%-529.95K | -29.31%-938.34K | -157.80%-132.58K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.